Articles & Video
Decentralized and Hybrid Clinical Trials Report 2020
Our Decentralized and Hybrid Clinical Trials Report looks at how the industry is adopting virtual trials, as well as challenges that need to be overcome.
Clinical Trials Content Library: Whitepapers and Reports Collection
Explore our collection of exclusive whitepapers and reports covering the hottest topics in clinical trials with one simple registration.
REPORT: Diversity, Equity and Inclusion in the Life Sciences 2021
Explore the Diversity, Equity and Inclusion in the Life Sciences 2021 report based on an exclusive study of 483 industry professionals.
Increasing diversity in clinical trials for COVID-19 vaccines and beyond
What has the COVID-19 pandemic taught us about how to achieve diversity in clinical trials?
Looking to 2030 Report: The Future of the Global Life Sciences and Pharma Industry
This exclusive report looks at predictions for how the global life sciences and pharma industry will change over the coming decade.
Clinical trial patient engagement: How technology is offering new approaches - WHITEPAPER
Clinical trial patient engagement: This whitepaper explores how technology is offering new approaches and assessments.
COVID-19 Report: The Response to and Impacts on the Global Life Sciences Industry
COVID-19 Report: How is the life sciences industry developing a vaccine, treatment and testing for COVID-19 and what impact is it having on supply chain?
Clinical Trials 2020 Digital Week: Full list of live webcasts
From remote trials to patient technology, we reveal the live webcast sessions running in this year's Clinical Trials Digital Week on June 1-4.
The Top 10 Posts of 2019: Clinical Trials Innovation
We look back at 2019's most popular articles on innovating clinical trials in an interactive flip-book.
How far can we trust AI in clinical trials?- INDUSTRY VOICES
Seven industry experts tell us what they see as the greatest challenges in using AI in clinical trials and how they can best be solved.
Virtual trials and Real World Evidence: The global shift in clinical operations
We deep-dive into our State of the Industry Report 2019 to understand how companies are utilizing virtual trials and Real World Evidence in their clinical trial operations.
Is AI really understood in the clinical trials industry? - Data report analysis
The latest State of the Industry 2019 survey revealed fascinating insights into what opportunities and obstacles organisations currently see in working with AI in clinical trials.
How TransCelerate is digitalizing patient engagement in clinical trials
Alison Bond, Director of Global Regulatory Policy & Intelligence at Janssen, explores the potential benefits of TransCelerate's Patient Technology Initiative.
Clinical Trials State of the Industry Report 2019
Clinical Trials State of the Industry 2019: Download the report offering insights into wearables, AI, virtual trials, partnerships and vendor oversight.
Clinical Trials Digital Week 2019 - 7 webinars on-demand
Register for Clinical Trials Digital Week 2019 for on-demand webinars and downloadable resources.
Low literacy issues and the Patient Information Leaflet
Former a senior research nurse Kate O’Brien looks at how low literacy levels in the UK present a challenge to effective Patient Information Leaflets for clinical trials.
Increasing research awareness and changing public perception of clinical trials
Site consultant Kate O’Brien looks at ways to increase research awareness to help boost patient engagement in clinical trials.
The Pain Clinic - Solving the five most common problems in clinical trials
Kate O’Brien examines the most common problems in all aspects of running clinical trials and the potential solutions to them.
The 10 most read posts of 2018
The 10 most read clinical trials posts of 2018 on data, patient-centricity, AI, partnerships and recruitment.
Forming clinical trial consortia is "definitely the future" - Dr. Raphaela Schnurbus
Dr. Raphaela Schnurbus, Clinical Solutions Director at CRO OPIS, discusses how partnerships in clinical trials are evolving and the challenges that still need to be overcome.
Clinical trials in 10 years: Data-driven personalized studies
How will clinical trials look in 10 years? Patricia Devitt Risse, President, Precision for Medicine, Oncology and Rare Disease makes her predictions